AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
ATEZOLIZUMAB in Tunisia
1 product registered with DPM — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TECENTRIQ Solution injectable pour perfusion / 1200mg | 6993261H | Roche Pharma (Schweiz) AG | expired | 22 Dec 2022 |
ATEZOLIZUMAB — DPM Registration Details
DPM (Tunisia) has 1 registered product containing ATEZOLIZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track ATEZOLIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.